FRANKFURT--The following is a summary of analysts' forecasts for Merck KGaA (MRK.XE) third-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million euros, EPS and target price in euro, according to IFRS). Earnings figures are scheduled to be released November 15.

=== 
                                                  Net 
               Sales:                         attrib. 
                                       EBITDA  income   EPS 
3rd Quarter    -total -Rebif -Erbitux     (a)     (a)   (a) 
AVERAGE         3,785    435      227   1,119     686  1.56 
Prev. Year      3,121    468      223     944     573  1.32 
+/- in %          +21   -7.1     +1.9     +19     +20   +18 
 
MEDIAN          3,778     --       --   1,117      --  1.57 
Maximum         3,841    451      234   1,133     696  1.60 
Minimum         3,743    425      223   1,110     668  1.50 
Amount (b)          5      3        3       6       3     6 
 
Deutsche Bank   3,743    425      225   1,125     693  1.59 
Equinet         3,841     --       --   1,110      --  1.50 
JP Morgan          --     --       --   1,133      --  1.57 
LBBW            3,778    428      234   1,110     668  1.54 
Morgan Stanley  3,802    451      223   1,114      --  1.57 
 
 
            Target price  Rating 
AVERAGE           101.17  positive 2 
Prev. Quarter     101.39  neutral  4 
+/- in %            -0.2  negative 0 
 
MEDIAN            100.00 
Maximum           117.00 
Minimum            91.00 
Amount                 6 
 
Commerzbank       101.00  Buy 
Deutsche Bank     117.00  Buy 
Equinet            91.00  Neutral 
Goldman Sachs      99.00  Neutral 
JP Morgan          96.00  Neutral 
Morgan Stanley    103.00  Equalweight 
=== 

Year-earlier figures are as reported by the company.

(a) Pre one-time items.

(b) Including anonymous estimates from one more analyst.

DJG/voi 

(END) Dow Jones Newswires

November 11, 2016 08:26 ET (13:26 GMT)